Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
47,950,622
-
Share change
-
+472,605
-
Total reported value
-
$626,233,206
-
Put/Call ratio
-
0%
-
Price per share
-
$13.06
-
Number of holders
-
93
-
Value change
-
+$2,428,146
-
Number of buys
-
35
-
Number of sells
-
45
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2021
As of 30 Sep 2021,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,950,622 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, BlackRock Inc., JANUS HENDERSON GROUP PLC, FEDERATED HERMES, INC., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.